New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 12, 2013
06:32 EDTINFIInfinity Pharmaceuticals downgraded to Neutral from Outperform at Credit Suisse
Credit Suisse downgraded Infinity Pharmaceuticals due to limited 2014 clinical data expected, an evolving competitive landscape, and risk of class and drug specific safety issues. Price target remains $20.
News For INFI From The Last 14 Days
Check below for free stories on INFI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 9, 2014
17:25 EDTINFIPoint72 Asset lowers passive stake in Infinity Pharmaceuticals to 7.1% from 7.5%
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use